References
- Groves F D, Linet M S, Travis L B, Devesa S S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240–1251
- Howe H L, Wingo P A, Thun M J, Ries L A, Rosenberg H M, Feigal E G, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001; 93: 824–842
- Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995; 310: 1491–1495
- McKenna, Stockton D, Brewster D H, Doherty V R. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy cohort study in Scotland. Br J Cancer 2003; 88: 74–78
- Lens M B, Newton-Bishop J A. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005; 16: 460–465
- McKenna D B, Doherty V R, McLaren K M, Hunter J A. Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?. Br J Dermatol 2000; 143: 171–173
- The international Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin's lymphoma: The International NHL Prognostic Factors Project. N Eng J Med 1993; 329: 987–994
- Tsao H, Kwitkiwski K, Sober A J. A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma. J Am Acad Dermatol 2002; 46: 55–61
- Abel E, Sendagorta E, Hoppe R. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides. J Am Acad Dermatol 1986; 14: 1029–1038
- Cahill R A, McGreal G, Neary P, Redmond H P. Synchronous high-risk melanoma and lymphoid neoplasia. Melanoma Res 2001; 11: 517–522
- Castella A, Mason N, Clarke G, Feldman A. Coexistence of malignant melanoma, Hodgkin's disease and follicular lymphoma with expression of the B-cell leukaemia/lymphoma (bcl-2) oncogene. Histopathology 1999; 35: 387–388
- Chaudhuri P K, Walker M J, Das Gupta K T. Cutaneous malignant melanoma after immunosuppressive therapy. Arch Surg 1980; 115: 322–323
- Crocetti E, Carli P. Risk of second primary cancers, other than melanoma, in an population-based cohort of cutaneous malignant melanoma patients. Eur J Cancer Prev 2004; 13: 33–37
- Evans A, Scarisbrick J, Child F J, Acland K M, Whittaker S J, Russell-Jones R. Cutaneous malignant melanoma in association with mycosis fungoides. J Am Acad Dermatol 2004; 50: 701–705
- Falk S, Walther F, Denk R. Metastatic malignant melanoma in a patient with non-Hodgkin's lymphoma. Hautarzt 1996; 47: 716–718
- Flindt-Hansen H, Brandrup F. Malignant melanoma associated with mycosis fungoides. Dermatologica 1984; 169: 167–168
- Gilbert T, Evjy J, Lee Edelstein. Hodgkin's disease associated with Kaposi's sarcoma and malignant melanoma. Cancer 1971; 28: 293–298
- Koeppel M -C, Grego F, Andrac L, Berbis P. Primary cutaneous large B-cell lymphoma of the legs melanoma: coincidence or association?. Br J Dermatol 1998; 139: 738–759
- Kyriakis K, Stavropoulos P, Hatziolou E, Dellidis G, Varelzidis A, Tosca A. Coexistence of pemphigus vulgaris, malignant melanoma and low-grade lymphoma. Dermatologica 1991; 183: 49–52
- Küchle M, Tiermann M, Holbach L, Naumann G O. Necrotic malignant melanoma of the choroid and concurrent intraocular manifestation of malignant non-Hodgkin's B cell lymphoma. Ophthalmologica 1994; 208: 65–70
- Licata A G, Wilson L D, Braverman I M, Feldman A M, Kacinski B M. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. Arch Dermatol 1995; 131: 432–435
- Moore G E, Cook D D. AIDS in association with malignant melanoma and Hodgkin's disease. J Clin Oncol 1985; 3: 1437
- Pruneri G, Mazzarol G, Manzotti M, Viale G. Monoclonal proliferation of germinal center cells (Incipient follicular lymphoma) in an axillary lymph node fa melanoma patient. Hum Pathol 2001; 32: 1410–1413
- Reseghetti A, Tribbia G, Locati F, Naldi L, Marchesi L. Cutaneous malignant melanoma appearing during photochemotherapy of mycosis fungoides. Dermatology 1994; 189: 75–77
- Soong V, Lee P C, Kissel R B, Sams W M, Jr, Tyring S K. Fatal malignant melanoma associated with a completely regressed primary melanoma in a patient with cutaneous T-cell lymphoma. Arch Dermatol 1987; 123: 1270–1272
- Tashima C K. Association of malignant melanoma and malignant lymphoma. Lancet 1973; 2: 266
- Curtis R E, Rowlings P A, Deeg H J, Shriner D A, Socie G, Travis L B, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897–904
- Brash D E, Rudolph J A, Simon J A, Lin A, McKenna G J, Baden H P, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124–10128
- Adami J, Gridley G, Nyren O, Dosemeci M, Linet M, Glimelius B, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641–645
- Boldeman C, Brandt L, Berg L, Ekbom A, Hall P. Risk of non-Hodgkin's lymphoma and skin malignancies in patients diagnosed with cataract. Eur J Cancer Prev 2004; 13: 281–285